Sentence examples for much lower fraction from inspiring English sources

China's overall savings rate has gone up in recent years because Chinese corporations are earning and saving more, while household consumption is low because Chinese households earn a much lower fraction of the income generated by the economy than in other countries.

That's a much lower fraction than the Gehring team's 100%.

With a much lower fraction of carbon additive for a commercial LIB, only 0.2 wt% graphene nanosheet (GN) together with 1 wt% Super-P (SP) constructing an effective conductive network, the prepared battery exhibits outstanding cycling stability (146 matg−1Cat 1C with retention of 96.4% after 50 cycles) and rate capability (116.5 mAhg−1 even at 5C).

However, intermediate strain (20 50%) followed by long-time annealing introduced a GBCD of a much lower fraction of ∑9 and ∑27 boundaries, the value of f∑9+∑27/f∑3 was only around 0.03 and the connectivity of HAB network was not interrupted basically.

That study used T2*-discriminated rather than T2 -discriminated (used herein) 1H NMR signals at low static magnetic field, and while a direct relationship existed between the so-called T2*-defined bound water and peak stress, it described a much lower fraction of the peak stress variance (r2 = 0.36, compared to 0.68, above).

Remarkably, the latter group manifested much lower fraction of NEA-positive genes at any significance threshold (two- to four-fold; Figure S6 in Additional file 1).

Unlike synthetic polymers, however, the comparably stiff nature of a biopolymer leads to mechanical integrity already at much lower volume fraction or mesh sizes, thereby still allowing molecular transport.

Interestingly, nano-sized particles show optimal wear benefits at much lower volume fractions than are required when using micro-sized filler materials.

The much lower complexed fractions from experimental data may indicate that in vivo, other soluble receptors (e.g., sVEGFR2, sNRP1, plasma fibronectin) can strongly compete with sVEGFR1 as plasma reservoirs for VEGF, or significant quantities of other ligands (e.g., PlGF, VEGF-B) are present to compete with VEGF for sVEGFR1 binding.

The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions--all < 1%.

Figure 6 then shows that selecting a PEG3000 polymeric porogen with much lower weight fractions of only 1 4 wt % in the polymerization precursor mixture allows tailoring of mesoporous properties.